| Product Code: ETC13203753 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Cell and Gene Therapy Manufacturing Quality Control Market was valued at USD 1.1 Billion in 2024 and is expected to reach USD 2.3 Billion by 2031, growing at a compound annual growth rate of 6.00% during the forecast period (2025-2031).
The Global Cell and Gene Therapy Manufacturing Quality Control Market is experiencing significant growth driven by the increasing adoption of advanced cell and gene therapies, coupled with stringent regulatory requirements for ensuring product quality and safety. Quality control measures play a crucial role in the manufacturing process of these therapies, ensuring consistent product quality and compliance with regulatory standards. Key market players are focusing on developing innovative technologies and solutions to enhance quality control processes, such as advanced analytics, automation, and real-time monitoring systems. The market is also witnessing collaborations between biopharmaceutical companies and contract manufacturing organizations to streamline quality control operations and meet the growing demand for cell and gene therapy products. Overall, the market is poised for continued expansion as the cell and gene therapy sector continues to evolve and mature.
The Global Cell and Gene Therapy Manufacturing Quality Control Market is experiencing significant growth driven by the increasing adoption of advanced therapies, regulatory approvals, and technological advancements. Key trends include the integration of automation and robotics in quality control processes to improve efficiency and consistency, the development of innovative analytical tools for product characterization, and the emphasis on ensuring product safety and efficacy through stringent quality control measures. Opportunities in the market include the expansion of manufacturing capacity to meet growing demand, collaborations between industry players to enhance quality control capabilities, and the potential for regulatory harmonization to streamline approval processes. Overall, the market is poised for continued expansion as cell and gene therapies become more mainstream, creating promising prospects for stakeholders in the quality control segment.
The Global Cell and Gene Therapy Manufacturing Quality Control Market faces challenges such as the need for standardized manufacturing processes to ensure consistent quality, scalability of production to meet growing demand, and regulatory complexities due to the innovative nature of these therapies. Maintaining the integrity and potency of cell and gene therapies throughout the manufacturing process poses a significant challenge, as any deviations in quality control can impact patient safety and treatment efficacy. Additionally, the high cost of quality control measures and the shortage of skilled personnel proficient in the specialized techniques required for this industry further compound the challenges faced by companies operating in this market. Effective quality control strategies and compliance with regulatory requirements are crucial for the success and widespread adoption of cell and gene therapies.
The Global Cell and Gene Therapy Manufacturing Quality Control Market is primarily driven by the increasing adoption of advanced cell and gene therapies for treating a wide range of diseases, leading to a growing demand for quality control measures to ensure the safety, efficacy, and consistency of these innovative therapies. Stringent regulatory requirements and guidelines for manufacturing and quality control processes also play a significant role in driving the market, as companies strive to comply with industry standards and ensure product quality. Additionally, the continuous advancements in analytical technologies and techniques for quality control, along with the rising investments in research and development activities within the cell and gene therapy sector, further contribute to the growth of the market by enhancing manufacturing processes and product quality.
Government policies related to the Global Cell and Gene Therapy Manufacturing Quality Control Market vary across regions. In the United States, the Food and Drug Administration (FDA) plays a crucial role in regulating the quality control of cell and gene therapy manufacturing through its Current Good Manufacturing Practice (cGMP) guidelines. These guidelines ensure that manufacturing facilities adhere to strict quality control measures to guarantee the safety, efficacy, and purity of cell and gene therapy products. In Europe, the European Medicines Agency (EMA) also enforces similar regulations under the Good Manufacturing Practice (GMP) framework. Both regulatory bodies require manufacturers to establish robust quality control systems, conduct thorough testing, and maintain detailed documentation throughout the manufacturing process to meet stringent quality standards and ensure patient safety.
The Global Cell and Gene Therapy Manufacturing Quality Control Market is poised for significant growth in the coming years as the demand for advanced therapies continues to rise. Factors such as increasing investments in research and development, technological advancements, and a growing focus on personalized medicine are driving the expansion of this market. Quality control measures play a crucial role in ensuring the safety and efficacy of cell and gene therapy products, making them essential for market growth and regulatory compliance. With the increasing adoption of these innovative therapies and the need for stringent quality control standards, the market is expected to experience steady growth and attract more players offering specialized solutions and services to meet the evolving needs of the industry.
In the global Cell and Gene Therapy Manufacturing Quality Control market, different regions showcase distinct trends. Asia is emerging as a key player due to its growing biotech industry and supportive regulatory environment. North America leads in terms of advanced technology adoption and established infrastructure. Europe boasts a strong network of academic institutions and research centers, fostering innovation in quality control practices. The Middle East and Africa are witnessing a gradual uptick in investment and partnerships in this sector. Latin America shows potential for market growth with increasing government initiatives and collaborations. Overall, the global Cell and Gene Therapy Manufacturing Quality Control market is characterized by a diverse landscape with each region contributing unique strengths and opportunities for market development.
Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, 2021 & 2031F |
3.3 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Industry Life Cycle |
3.4 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Porter's Five Forces |
3.5 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.7 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By Analytical Method, 2021 & 2031F |
3.8 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By Process, 2021 & 2031F |
3.9 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market Trends |
6 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, 2021 - 2031 |
6.1 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Component, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Equipment & Accessories, 2021 - 2031 |
6.1.3 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Consumables, 2021 - 2031 |
6.1.4 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Analytical Method, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Sterility Testing, 2021 - 2031 |
6.2.3 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Purity Testing, 2021 - 2031 |
6.2.4 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Potency Testing, 2021 - 2031 |
6.2.5 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Identity Testing, 2021 - 2031 |
6.2.6 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Process, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Upstream Processes, 2021 - 2031 |
6.3.3 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Downstream Processes, 2021 - 2031 |
6.3.4 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Process Development, 2021 - 2031 |
6.4 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By End-user, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021 - 2031 |
6.4.3 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Contract Manufacturing Organizations, 2021 - 2031 |
7 North America Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Overview & Analysis |
7.1 North America Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, 2021 - 2031 |
7.2 North America Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Component, 2021 - 2031 |
7.4 North America Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Analytical Method, 2021 - 2031 |
7.5 North America Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Process, 2021 - 2031 |
7.6 North America Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By End-user, 2021 - 2031 |
8 Latin America (LATAM) Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Overview & Analysis |
8.1 Latin America (LATAM) Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Component, 2021 - 2031 |
8.4 Latin America (LATAM) Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Analytical Method, 2021 - 2031 |
8.5 Latin America (LATAM) Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Process, 2021 - 2031 |
8.6 Latin America (LATAM) Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By End-user, 2021 - 2031 |
9 Asia Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Overview & Analysis |
9.1 Asia Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Component, 2021 - 2031 |
9.4 Asia Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Analytical Method, 2021 - 2031 |
9.5 Asia Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Process, 2021 - 2031 |
9.6 Asia Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By End-user, 2021 - 2031 |
10 Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Overview & Analysis |
10.1 Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Component, 2021 - 2031 |
10.4 Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Analytical Method, 2021 - 2031 |
10.5 Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Process, 2021 - 2031 |
10.6 Africa Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By End-user, 2021 - 2031 |
11 Europe Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Overview & Analysis |
11.1 Europe Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Component, 2021 - 2031 |
11.4 Europe Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Analytical Method, 2021 - 2031 |
11.5 Europe Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Process, 2021 - 2031 |
11.6 Europe Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By End-user, 2021 - 2031 |
12 Middle East Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Overview & Analysis |
12.1 Middle East Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Component, 2021 - 2031 |
12.4 Middle East Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Analytical Method, 2021 - 2031 |
12.5 Middle East Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By Process, 2021 - 2031 |
12.6 Middle East Cell and Gene Therapy Manufacturing Quality Control (QC) Market, Revenues & Volume, By End-user, 2021 - 2031 |
13 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market Key Performance Indicators |
14 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Export/Import By Countries Assessment |
15 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Opportunity Assessment |
15.1 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By Component, 2021 & 2031F |
15.3 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By Analytical Method, 2021 & 2031F |
15.4 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By Process, 2021 & 2031F |
15.5 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By End-user, 2021 & 2031F |
16 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Competitive Landscape |
16.1 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenue Share, By Companies, 2024 |
16.2 Global Cell and Gene Therapy Manufacturing Quality Control (QC) Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here